Skan AG leads the market in providing essential isolator systems for drug filling processes. With the rise of biopharmaceuticals, demand for Skan's products has soared. These systems are crucial for maintaining aseptic conditions during the filling of biopharmaceuticals, which generally can't be sterilised with heat.

Skan's main offerings include modular isolators and closed-vial filling systems, serving major players like Novo Nordisk, Lilly, GSK, Novartis, and Pfizer. While Skan operates globally, Europe accounts for 57% of its revenue. The company enjoys strong customer loyalty, as its products are integral to drug manufacturing supply chains.